Skip to main content

Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.

Publication ,  Journal Article
Egilman, AC; Zhang, AD; Wallach, JD; Ross, JS
Published in: Annals of internal medicine
October 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Annals of internal medicine

DOI

EISSN

1539-3704

ISSN

0003-4819

Publication Date

October 2019

Volume

171

Issue

7

Start / End Page

521 / 523

Related Subject Headings

  • United States
  • Stereoisomerism
  • Prescription Drugs
  • Medicare Part D
  • Humans
  • General & Internal Medicine
  • Databases, Pharmaceutical
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Egilman, A. C., Zhang, A. D., Wallach, J. D., & Ross, J. S. (2019). Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors. Annals of Internal Medicine, 171(7), 521–523. https://doi.org/10.7326/m19-1085
Egilman, Alexander C., Audrey D. Zhang, Joshua D. Wallach, and Joseph S. Ross. “Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.Annals of Internal Medicine 171, no. 7 (October 2019): 521–23. https://doi.org/10.7326/m19-1085.
Egilman AC, Zhang AD, Wallach JD, Ross JS. Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors. Annals of internal medicine. 2019 Oct;171(7):521–3.
Egilman, Alexander C., et al. “Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.Annals of Internal Medicine, vol. 171, no. 7, Oct. 2019, pp. 521–23. Epmc, doi:10.7326/m19-1085.
Egilman AC, Zhang AD, Wallach JD, Ross JS. Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors. Annals of internal medicine. 2019 Oct;171(7):521–523.

Published In

Annals of internal medicine

DOI

EISSN

1539-3704

ISSN

0003-4819

Publication Date

October 2019

Volume

171

Issue

7

Start / End Page

521 / 523

Related Subject Headings

  • United States
  • Stereoisomerism
  • Prescription Drugs
  • Medicare Part D
  • Humans
  • General & Internal Medicine
  • Databases, Pharmaceutical
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences